Advanced Search

 

Study ID Status Title Patient Level Data
114568 Completed A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% IN THE TREATMENT OF SEBORRHEIC DERMATITIS Study Listed on ClinicalStudyDataRequest.com
114571 Completed A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Cumulative Irritation Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114572 Completed A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Contact Sensitization Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114573 Completed A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled Study To Evaluate The Phototoxic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114574 Completed A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Photoallergic Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
114575 Completed A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects with Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
114576 Completed A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects with Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
114580 Completed An Evaluation of the Bioequivalence of a Combined Formulated Tablet (50mg/600mg/300mg dolutegravir/abacavir/lamivudine)Compared to One Dolutegravir 50mg Tablet and One EPZICOM† (600mg/300mg abacavir/lamivudine) Tablet Administered Concurrently and the Effect of Food on Bioavailability of the Combined Formulation in Healthy Adult Subjects
114581 Completed A Randomized, Open-Label, Single‑Dose, 3‑Period, Crossover Evaluation of the Relative Bioavailability of Two Experimental Fixed-Dose Combination Tablet Formulations of Dolutegravir 50 mg/Abacavir 600 mg/Lamivudine 300 mg Compared to Co‑administered Dolutegravir 50 mg and EPZICOM™ (Abacavir 600 mg/Lamivudine 300 mg) Tablets in Healthy Adult Subjects
114582 Completed A Randomized, Placebo-Controlled Study to Evaluate the Effect of Tafenoquine (SB252263) on the Electrocardiogram (ECG) with Focus on Cardiac Repolarization (QTc duration) in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
114590 Completed Immunogenicity and safety study of GSK Biologicals’ HPV vaccine (GSK 580299) in healthy adult Chinese female subjects Study Listed on ClinicalStudyDataRequest.com
114591 Completed Incidence of colonic ischemia, hospitalized complications of constipation, and bowel surgery in relation to use of alosetron hydrochloride
114592 Completed Bupropion and specific cardiovascular malformations
114593 Completed WEUSRTP4850: Phase II: Asthma treatment in pregnancy and the frequency of adverse pregnancy outcomes
114594 Completed An exploratory First Time in Human (FTIH) study investigating the pharmacokinetics (PK), immunogenicity, safety and tolerability of GSK2434735 administered as a single low dose in healthy male subjects Study Listed on ClinicalStudyDataRequest.com
114595 Completed A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of GSK2140944 in Healthy Adult Subjects
114604 Completed A single dose, crossover study in healthy female subjects to assess the regional absorption and bioavailability of 100 mg GSK2190915A Study Listed on ClinicalStudyDataRequest.com
114606 Completed Post-marketing observational retrospective study of patients who received the dosimetric dose of the BEXXAR® therapeutic regimen (tositumomab and iodine I 131 tositumomab) in the commercial setting: assessment of altered biodistribution
114609 Completed A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects with post-stroke focal upper limb spasticity
114615 Completed Comparative efficacy of Dutasteride plus tamulsoin with lifestyle advice versus watchful waiting plus lifestyle advice with step-up therapy to tamsulosin in the management of treatment naïve men with moderately symptomatic benign prostatic hyperplasia and prostate enlargement.
114619 Completed A Nation-wide,multi-center, observational, cross-sectional, epidemiologic study to evaluate the proportion of Cardiovascular disease Risk Factors in Korean hypertensive patients
114622 Completed A two part study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2586881 in patients with acute lung injury
114624 Completed A randomised, repeat-dose, placebo-controlled, double-blind study to evaluate and compare the efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder, when administered either in the morning or in the evening, in male and female asthmatic subjects Study Listed on ClinicalStudyDataRequest.com
114634 Completed A 24-week randomised, double-blind and placebo-controlled study to evaluate the efficacy and safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder compared with placebo Inhalation Powder delivered once-daily via a Novel Dry Powder Inhaler in subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
114635 Completed A randomised, placebo-controlled, incomplete block, four period crossover , repeat dose study to evaluate the effect of the inhaled GSK573719/Vilanterol combination and GSK573719 monotherapy on electrocardiographic parameters, with moxifloxacin as a positive control, in healthy subjects. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.